Related Experiment Video

Updated: Mar 30, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.6K

Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation

Sun Joo Lee1, Ji Yun Jeong2,3, Chang Joo Oh2

  • 1Department of Biomedical Science, Graduate School of Medicine, Kyungpook National University.

Scientific Reports
|November 13, 2015
PubMed

Insights

Pyruvate dehydrogenase kinase 4 (PDK4) promotes vascular calcification by enhancing osteogenic markers. Inhibiting PDK4 reduces calcification without affecting bone formation, identifying it as a potential therapeutic target.

Area of Science:

  • Cardiovascular Biology
  • Biochemistry
  • Pathology

Background:

  • Vascular calcification is linked to cardiovascular disease and involves abnormal calcium and phosphate regulation.
  • Pyruvate dehydrogenase kinase 4 (PDK4) is implicated in pathological processes.

Purpose of the Study:

  • To investigate the role of PDK4 in vascular calcification.
  • To explore PDK4 as a potential therapeutic target for vascular calcification.

Main Methods:

  • Examined PDK4 expression in calcifying vascular smooth muscle cells (VSMCs) and human atherosclerotic vessels.
  • Utilized genetic and pharmacological inhibition of PDK4 in vitro and in vivo models.
  • Assessed the effect of PDK4 on VSMC osteogenic differentiation, BMP2 signaling, and mitochondrial function.

Main Results:

  • PDK4 was upregulated in calcifying VSMCs and atherosclerotic vessels.
  • Inhibition of PDK4 ameliorated vascular calcification in cellular and animal models.
  • PDK4 enhanced VSMC osteogenic differentiation by phosphorylating SMAD1/5/8, activating BMP2 signaling.
  • Increased PDK4 induced mitochondrial dysfunction and apoptosis in VSMCs.

Conclusions:

  • Upregulated PDK4 promotes vascular calcification by increasing osteogenic markers.
  • PDK4 inhibition is a promising therapeutic strategy for vascular calcification without adverse bone effects.

More Related Videos

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

2.2K
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.6K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K